Composition for pulmonary administration comprising a drug and a hydrophobic amino acid

   
   

According to the subject invention, dispersible dry powder pharmaceutical-based compositions are provided, including methods for their manufacture and dry powder dispersion devices. A dispersible dry powder pharmaceutical-based composition is one having a moisture content of less than about 10% by weight (% w) water, usually below about 5% w and preferably less than about 3% w; a particle size of about 1.0-5.0 m mass median diameter (MMD), usually 1.0-4.0 m MMD, and preferably 1.0-3.0 m MMD; a delivered dose of about 30%, usually 40%, preferably 50%, and most preferred 60%; and an aerosol particle size distribution of about 1.0-5.0 m mass median aerodynamic diameter (MMAD), usually 1.5-4.5 m MMAD, and preferably 1.5-4.0 m MMAD. Such compositions are of pharmaceutical grade purity.

 
Web www.patentalert.com

< Methods for inhibition of membrane fusion-associated events, including HIV transmission

< Tricyclic compounds useful as HIV reverse transcriptase inhibitors

> Method and tool for prognosticating HIV infection in a subject by measuring soluble urokinase plasminogen activator receptor, degradation products thereof, and urokinase plasminogen activator receptor

> Method of folding gloves and dispenser therefor

~ 00195